Abstract
Superoxide dismutase (SOD) is produced in every human cells to prevent from the auto-oxidative damages by increasingly released oxygen-intermediates. We tried to treat with liposomal SOD 9 patients with intractable diseases, 3 PSS, 1 PM, 1 PSS+DM, 1 SLE+PM, 2 Behçet's disease and 1 paraquart intoxication. The patients were administered liposomal SOD at 2.5 mg/body 3 times in a week for one or two months. Two weeks after the administration, 4 patients with PSS and PM were significant improvement in their clinical symptoms such as palpitation and shortness of breath, and also % VC incresed to nearly normal range. An another patient with SLE plus PM who had chest oppression feeling due to myocardiopathy was also improvement. However liposomal SOD was not effective in a case of Behçet's disease. We think that liposomal SOD may be useful for intractable diseases, particularly when conventional therapies have failed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
